Medically-assisted reproduction not associated with negative psychiatric effectsMarch 30th 2023
In a recent study, women who underwent medically-assisted reproduction were more likely to experience negative psychiatric effects because of remaining childless after treatment.
Neurodevelopmental disorders from in utero COVID-19 exposure based on sexMarch 28th 2023
In a recent study, female offspring of mothers with a positive COVID-19 test during pregnancy were at a decreased risk of developing neurodevelopmental disorders compared to male offspring.
Managing hyperglycemia in hospitalized adultsMarch 27th 2023
The 2012 Management of Hyperglycemia in Hospitalized Patients in Non-Critical Care Settings: An Endocrine Society Clinical Practice Guideline was recently reviewed by a panel of clinician experts for use in adults hospitalized with hyperglycemia.
Relugolix combination therapy effective against symptomatic uterine fibroidsMarch 24th 2023
In a recent study, women with symptomatic uterine fibroids saw reduced symptom burden and improved quality of life after 24 weeks of treatment through relugolix combination therapy.
FDA gives clearance and CLIA waiver to second generation sexual health testMarch 21st 2023
Visby Medical has announced its second generation point of care test for detecting sexually transmitted diseases in women has received 510(k) clearance and a CLIA waiver from the FDA.
Covis withdraws Makena from the marketMarch 9th 2023
Covis, the manufacturer of the controversial preterm birth prevention drug Makena, has announced it will voluntarily withdraw the drug from the market after recommendations from the Center for Drug Evaluation and Research.